H-L-Val-OBzl*Tos

H-L-Val-OBzl*Tos is an L-valine benzyl ester bearing a tosylated benzyl group (OBzl*Tos) that functions as a protected amino acid ester for downstream peptide and derivative synthesis. The molecule retains the valine stereocenter in the S-configuration and presents a valyl backbone with an esterified carboxylate, while the N-terminus is protected as an amino acid residue suitable for coupling chemistry. The benzyl ester motif can be deprotected under controlled conditions to regenerate a free carboxylic acid for peptide bond formation, and the tosylated component introduces an additional leaving-group and handle for orthogonal transformations. The combination of a chiral amino acid framework with a protected carboxyl functionality supports stereochemically defined fragment assembly and subsequent conversion into carboxamide, mixed anhydride, or activated acid derivatives used in synthetic organic chemistry and biochemical research.

1. Peptide Synthesis

H-L-Val-OBzl*Tos is applied as an L-valine ester building block in peptide synthesis workflows where controlled C-terminal protection is required. The valine side chain (isopropyl) provides a nonpolar handle that remains stable under standard peptide coupling conditions, while the benzyl ester carboxyl protection enables selective activation after deprotection to form a C-terminal activated acid. The N-protected amino acid residue can participate in peptide coupling strategies to generate amide linkages with target sequences while maintaining the L-configuration at the stereocenter. Downstream peptide fragment construction benefits from the ester-to-acid conversion step, enabling access to both linear peptide intermediates and protected peptide analogs for further elaboration.

2. Protected Amino Acid Chemistry

H-L-Val-OBzl*Tos is suitable for protected amino acid synthesis and orthogonal protection planning due to its ester-protected carboxyl group and tosylated functionality. The benzyl ester format supports a predictable deprotection-to-carboxylic acid transformation, which can be leveraged to switch between ester-stable intermediates and acid-reactive species during multistep synthesis. The presence of the tosylated component can enable additional derivatization routes that maintain stereochemical integrity of the chiral valine core. Synthetic sequences can therefore be designed to access activated valine derivatives for subsequent coupling, amidation, or formation of peptide-like scaffolds while controlling functional group exposure.

3. Chiral Building Block Development

H-L-Val-OBzl*Tos serves as a chiral amino acid intermediate for stereodefined fragment generation in asymmetric or stereospecific synthesis. The L-valine stereocenter is preserved within the amino acid ester, allowing incorporation into larger chiral frameworks through peptide coupling or amide-forming transformations after appropriate activation of the carboxyl group. The side-chain isopropyl group contributes hydrophobic character that can influence conformational preferences in peptidomimetic and SAR-focused constructs, while the protected termini reduce side reactions during fragment assembly. Downstream use can include preparation of enantiopure peptide segments, chiral standards, and stereochemically defined intermediates for structure-activity relationship studies in medicinal chemistry programs.

4. Chemical Manufacturing Intermediates

H-L-Val-OBzl*Tos is relevant to process chemistry and specialty chemical production as a protected amino acid ester intermediate that can be manufactured and handled through established fine-chemical routes. The benzyl ester protection strategy supports controlled reactivity during scale-up, enabling sequential conversion between protected and activated carboxyl forms without exposing free acids that may complicate downstream steps. The tosylated functionality provides an additional chemical handle for transformation during intermediate purification and route optimization, aligning with industrial needs for predictable functional group management. The resulting valine-derived intermediates can be routed toward peptide building block preparation, amide-containing intermediate manufacture, and other amino acid derivative syntheses used in applied chemical production.

5. Peptidomimetics And SAR Studies

H-L-Val-OBzl*Tos can be employed in peptidomimetic construction and SAR studies where valine residues are incorporated as stereochemically defined hydrophobic units. The valine ester framework enables generation of peptide-like amide bonds after conversion to an acid-activated form, supporting assembly of analog libraries with controlled stereochemistry. The preserved L-configuration and stable side-chain under coupling conditions help maintain consistent structural features across analog series, which is important for comparative structure-activity relationship investigations. Downstream derivatives may include constrained peptide analog fragments, protease-stable mimetics, and other valine-containing scaffolds used to probe molecular recognition and binding mode hypotheses in research chemistry.

1. High fat diet and GLP-1 drugs induce pancreatic injury in mice

2. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

3. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

4. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

5. Cationic cell-penetrating peptides are potent furin inhibitors